GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Porton Pharma Solutions Ltd (SZSE:300363) » Definitions » 5-Year Yield-on-Cost %

Porton Pharma Solutions (SZSE:300363) 5-Year Yield-on-Cost % : 198.78 (As of May. 28, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Porton Pharma Solutions 5-Year Yield-on-Cost %?

Porton Pharma Solutions's yield on cost for the quarter that ended in Mar. 2024 was 198.78.


The historical rank and industry rank for Porton Pharma Solutions's 5-Year Yield-on-Cost % or its related term are showing as below:

SZSE:300363' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.91   Med: 7.09   Max: 202.05
Current: 198.78


During the past 13 years, Porton Pharma Solutions's highest Yield on Cost was 202.05. The lowest was 1.91. And the median was 7.09.


SZSE:300363's 5-Year Yield-on-Cost % is ranked better than
99.8% of 503 companies
in the Drug Manufacturers industry
Industry Median: 2.13 vs SZSE:300363: 198.78

Competitive Comparison of Porton Pharma Solutions's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Porton Pharma Solutions's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Porton Pharma Solutions's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Porton Pharma Solutions's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Porton Pharma Solutions's 5-Year Yield-on-Cost % falls into.



Porton Pharma Solutions 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Porton Pharma Solutions is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Porton Pharma Solutions  (SZSE:300363) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Porton Pharma Solutions 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Porton Pharma Solutions's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Porton Pharma Solutions (SZSE:300363) Business Description

Traded in Other Exchanges
N/A
Address
Fangzheng Avenue, Porton New Drug Outsourcing Service and R&D Center, Shuitu, Beibei District, Chongqing, CHN, 400714
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Executives
Wang Zhong Neng Executives
Yu Yong Mei Executives
Sun Min Executives
Ji Yao Hui Executives
Ju Nian Feng Directors, executives
Tan Jun Supervisors
Xu Ai Wu Directors, executives
Guo Yong Qing Independent director
Director
Director
Ceng Hui Supervisors
Chen Bei Executives

Porton Pharma Solutions (SZSE:300363) Headlines

No Headlines